Neurofilament light as a biomarker in subarachnoid hemorrhage


  • Concentrations of neurofilament light (NfL) in the cerebrospinal fluid (CSF) and serum following subarachnoid hemorrhage (SAH) are predictive for SAH clinical outcomes.

Why this matters

    Use of NfL as a biomarker in SAH helps describe variance in clinical outcomes; NfL concentration has potential application as an endpoint in clinical trials or to tailor clinical care to predicted progression.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.